baber/WOPTO huggingface dataset:
Patent FI-894951-A0 (FI)
Inventor: ISSENMANN EDOUARD
IPC: H04W88/14
Filed: 1989-10-18
Abstract: The switching centre of the invention comprises a switch for access to the service (11) and a monitoring point (12) which are connected by a multiplex connection (601). The switch is connected to base-station monitors by first multiplex connections (65) and to the switched public telephone network by second multiplex connections (610) also routing indicator signals relating to a permanent file, to a temporary file and to other switching centres. The switch establishes semi- permanent connections between the multiplex connection (601) connecting it to the monitoring point (12) and, on the one hand, the first multiplex connections (65) for an exchange of indicator signals, and, on the other hand, with the second multiplex connections (610) for an exchange of indicator signals with the permanent and temporary files and the other switching centres. 
<IMAGE>
Patent FI-901951-A0 (FI)
Inventor: KOENIG LARRY E
IPC: B02C19/22
Filed: 1990-04-18
Abstract: A shredder capable of grinding large objects to form material of a smaller predetermined size is described. A grinding chamber (20) is defined by a housing. Mounted within the chamber (20) is screw auger means (40, 42) using tapered flights. Motor means is provided to rotate the screw auger means. Hopper means (14) is positioned above the grinding chamber (20) to direct material therein to be shredded by the screw auger means (40, 42). Variable opening means (70, 72) are formed in the bottom of the grinding chamber below the screw auger means. An opening of a selected size allows material shredded by the screw auger means (40, 42) and reduced in size until it is sufficiently small to pass through the opening.
Patent FI-910671-A0 (FI)
Inventor: BROWN ROBERT A
IPC: B07B9/00
Filed: 1991-02-12
Abstract: A system and process for sizing wood chips to provide a flow of wood chips which are acceptable for feeding to a digester of a pulping system. A flow management screen station is rovided which divides an incoming unacceptable flow (F0) into two fractional flows (F1, F2), neither of which is acceptable for feeding to the digester. One of the output flows from the flow management screen is concentrated in oversized and overthick chips compared to the incoming flow. The other output flow is concentrated in undersized chips and particles compared to the incoming flow. The output flows from the flow management screen are then fed to second and third screens (16, 14) which separate "overs" and "unders" from the respective flows to provide acceptable flows to the digester. <IMAGE>
Patent FI-911275-A0 (FI)
Inventor: AMLOT PETER LLOYD
IPC: A61P35/02
Filed: 1991-03-14
Abstract: Novel monoclonal antibodies to the CD25 antigen are characterized by the amino acid sequence of their hypervariable regions. Initially produced in murine form, they may be converted to chimeric or humanized forms, immunoconjugates or antibody fragments (generally described as binding molecules). The products are useful for the prophylaxis or treatment of transplant rejection, paticularly in combination with other antibodies to activated T-cells, for example CD7 antibodies.
Patent FI-921382-A0 (FI)
Inventor: KRINNER KLAUS
IPC: A47G33/12
Filed: 1992-03-30
Abstract: A Christmas-tree stand (2) features a foot-piece (4) with a connected holder (6) to which fastening components (14, 16, 18 and 20) are attached. In the example case, these components are swinging clamps which are pressed against the outer surface of the tree trunk by a clamping device (46). The pressure of the clamping device (46) is applied to the fastening components (14, 16, 18 and 20) via a steel cable (66), for example, which encircles them and is attached to the clamping device (46). The cable (66) moves the fastening components (14, 16, 18 and 20) toward the trunk with adjustable and evenly distributed force.
Patent FI-922926-A0 (FI)
Inventor: KALLIO ARJA
IPC: C12Q1/68
Filed: 1992-06-24
Abstract: The adequacy of clinical specimens for nucleic acid hybridization tests is determined by a method comprising the steps of (a) taking a representative sample from the specimen; (b) applying the sample, without intermediate treatment, to a gel having dispersed therein a nucleic acid staining agent such that the staining agent binds to the nucleic acids in the sample to produce a visually detectable product; and (c) visually determining the amount of staining agent bound to the sample and comparing this to the result obtained for a known concentration of deoxyribonucleic acid and staining agent in order to determine the approximate number of cells in the sample. Reagents and apparatus for performing the method may be packaged in kit form.
Patent FI-923575-A0 (FI)
Inventor: SCHILLING WALTER
IPC: A61K31/452
Filed: 1992-08-10
Abstract: 1-Acylpiperidine compound of the formula I    <IMAGE>  (I)  in which R1 is an optionally substituted aralkyl, aryloxyalkyl, heteroaralkyl, aroyl, heteroaroyl, cycloalkylcarbonyl, aralkanoyl, heteroarylalkanoyl, aralkoxycarbonyl or arylcarbamoyl radical or the acyl radical of an  alpha -amino acid which is optionally N-substituted by lower alkanoyl or carbamoyl-lower-alkanoyl, R2 is cycloalkyl or an optionally substituted aryl or heteroaryl radical, R3 is hydrogen, alkyl, carbamoyl or an alkanoyl or alkenoyl radical which is optionally substituted by carboxyl or esterified or amidated carboxyl, R4 is an optionally substituted aryl or optionally partially hydrogenated heteroaryl radical, X1 is methylene, ethylene, a direct linkage, an optionally ketalised carbonyl group or an optionally etherified hydroxymethylene group, X2 is alkylene, carbonyl or a direct linkage, and X3 is carbonyl, oxo-lower-alkylene, oxo(aza)-lower-alkylene or an alkylene radical which is optionally substituted by phenyl, hydroxymethyl, optionally esterified or amidated carboxyl or, in higher than the  alpha  position, by hydroxyl, and its salts have substance-P-antagonistic properties and can be used as pharmaceutically active substances in pharmaceuticals for the treatment of disorders in whose development substance P plays an essential part.
Patent FI-924462-A0 (FI)
Inventor: SLATER GLENN L
IPC: B29C65/02
Filed: 1992-10-02
Abstract: The invention describes a closed bag (12) made of a flexible plastic film for accommodation of liquids, which can be pierced with a spike connector through a spike connection piece (50). The spike connection piece (50) is sealed between two folds (32, 38) on one side (26) of the bag (12), so that the inner opening of the channel (60) adjoins the folded plastic film. The spike (80) is guided through the channel (60) of the spike connection piece (50) and pierces through the plastic film in order to tap the bag (12) and withdraw the liquid. Leaks are prevented by the seal between the plastic film and the spike (80) and the seal between the bag (12) and the spike connection piece (50). 
<IMAGE>
Patent FI-930452-A0 (FI)
Inventor: RUSTENBERG
IPC: A01N43/653
Filed: 1993-02-02
Abstract: The invention relates to novel fungicidal compositions based on cyproconazole and quaternary ammonium salts, which display surprisingly powerful synergistic activities in the control and prevention of wood-destroying fungi.
Patent FI-931097-A0 (FI)
Inventor: GEISSLINGER GERD
IPC: C07C57/58
Filed: 1993-03-11
Abstract: The present invention provides a medicament for the treatment of painful and/or inflammatory diseases and/or of fever with flurbiprofen, wherein the flurbiprofen is pure or preponderantly R(-)-flurbiprofen worked up in combination with conventional pharmaceutical carriers and adjuvants, to give a medicament.
Patent FI-934176-A0 (FI)
Inventor: BROOKSTEIN DAVID STUART
IPC: D04C1/06
Filed: 1993-09-23
Abstract: The present invention provides a vascular prosthesis which comprises a braided tubular fabric comprising a plurality of braid layers wherein each layer includes at least one interlocking yarn which extends from that layer into another layer to form an interlock therewith. In one aspect of the invention, the plurality of braid layers may include a substantially non-absorbable first surface layer and a substantially resorbable second surface layer.
Patent FI-945244-A0 (FI)
Inventor: ROWLAND SIMON MARK
IPC: G02B6/44
Filed: 1994-11-08
Abstract: PCT No. PCT/GB93/00947 Sec. 371 Date Oct. 25, 1994 Sec. 102(e) Date Oct. 25, 1994 PCT Filed May 7, 1993 PCT Pub. No. WO93/23779 PCT Pub. Date Nov. 25, 1993.A method of installing an optical cable in an overhead power transmission line by supporting an optical cable, which has an overall protective sheath of electrically insulating material, in long lengths between towers employed to support at least one electric power transmission line which is on load and, after the optical cable has been so installed and while the overhead electric power transmission line is on load, providing on or in the supported optical cable at least one longitudinally continuous path which extends throughout substantially the whole length of the supported optical cable and which is sufficiently electrically conductive to carry along the cable any currents that may be capacitively induced. The method enables a cable that will not be subject to dry-band arcing to be installed without danger to personnel during installation.
Patent FI-945777-A0 (FI)
Inventor: MEIER HEINRICH
IPC: C07D211/90
Filed: 1994-12-08
Abstract: The present invention relates to the compound rac-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyanophenyl)-1,4-dihydro-2,6-dimethylpyridine-3,5-dicarb oxylate and its pure enantiomers, to processes for the preparation thereof and to the use thereof as pharmaceutical, in particular for treatment of cerebral and neuronal disorders and to an intermediate for the preparation thereof.
Patent FI-951618-A0 (FI)
Inventor: DE CONINCK VALERE LEOPOLD MARI
IPC: A23L1/0522
Filed: 1995-04-05
Abstract: The present invention discloses a starch containing composition which is suitable for use as a replacement for gum arabic in foodstuff applications. Specifically the replacement is a combination of hydroxypropylated starch and hydrosed collagen.
Patent FI-953185-A0 (FI)
Inventor: LENTZ DAVID J
IPC: A61F2/06
Filed: 1995-06-27
Abstract: An implantable tubular prosthesis having cuffs adapted to accommodate stents. The prosthesis includes a hollow tubular conduit with cuffs at each end. Each of the cuffs has a closed end and a open end to create a slot for housing the stents. The prosthesis may be an implantable tubular intraluminal prosthesis for insertion within a body vessel, where the hollow tubular conduit is radially expandable to buttress the body vessel. Alternatively, the prosthesis may be an implantable tubular prosthetic graft for surgical replacement of damaged or diseased existing body vessels. The tubular prosthesis and stent combination may be radially expanded so that the stents anchor the prosthesis within the lumen. The slots which house the stents, prevent contact between the stents and fluids flowing through the body vessel. <MATH>
Patent FI-973435-A0 (FI)
Inventor: METZEMACHER HEINZ-DIETER
IPC: C08L23/00
Filed: 1997-08-21
Abstract: PCT No. PCT/EP96/00743 Sec. 371 Date Aug. 25, 1997 Sec. 102(e) Date Aug. 25, 1997 PCT Filed Feb. 22, 1996 PCT Pub. No. WO96/26240 PCT Pub. Date Aug. 29, 1996A filler composition for thermoplastic olefins or thermoplastic elastomers which comprises a halogen-free, flame-inhibiting filler which has been surface-treated with fatty acid derivatives and optionally a siloxane derivative.
Patent IL-78524-A0 (IL)
Title: Method of testing in the electronic field employing perfluoro-polyethers
IPC: C10N20/00
Filed: 1986-04-16
Abstract: Perfluoropolyethers having an average molecular weight higher than 390 and respectively having a kinematic viscosity lower than 8.5 cSt (at 20°C), and such as to distill by not more than 10% at temperatures lower than 140 °C, and by at least 90% at temperatures not higher than 260°C, or, in the case in which the perfluoropolyether does not contain CF-(CF<sub>3</sub>)CF,O units, having a viscosity lower than 18 cSt (at 20°C), and such as to distill by not more than 10% at temperatures lower than 140 °C, and by at least 90% at temperatures not higher than 280°C, are used as the only high-temperature and low- temperature working fluid in the Thermal Shock Tests to which the electronic components are submitted, and at the same time are advantageously used in other tests used in the electronic industry, such as the Gross Leak Test and the Burn in Test, allowing the operators in this field to use one single fluid for a whole set of uses.
Patent IL-92442-A0 (IL)
Title: Piperazinylalkyl-3(2h)-pyridazinones,their preparation and pharmaceutical compositions containing them
IPC: A61K31/501
Filed: 1989-11-24
Abstract: The invention relates to new piperazinylalkyl-3(2H)-pyridazinones of the formula   <IMAGE> I  in which the radicals R1 represents hydrogen, phenyl, benzyl, or (C1-C6)-alkyl which is unsubstituted or substituted one or more times by hydroxyl, piperidine, morpholine or by a group NR4R5 in which R4 and R5 can be identical or different and which represent hydrogen, methyl or ethyl, R2 and R3 represent hydrogen, halogen, (C1-C6)-alkoxy or (C1-C6)-alkyl, where at least one of the radicals R2 or R3 denotes hydrogen, R6 represents hydrogen, (C1-C4)-alkyl, phenyl, benzyl or phenylethyl, B represents (C1-C7)-alkylene which is unsubstituted or substituted one or more times by hydroxyl, (C1-C4)-alkyl or by the group NR4R5 and which can optionally be closed to form an alicyclic 4- to 7-membered ring, R8 and R9, which can be identical or different, represent hydrogen or (C1-C6)-alkyl and Z represents phenyl, naphthyl, pyridyl or thiazolyl, each of which can be unsubstituted or substituted one or more times by (C1-C6)-alkyl, (C1-C6)-alkoxy, benzyloxy, trifluoromethyl, halogen, nitro, (C3-C7)-cycloalkoxy, (C1-C4)-alkylthio, trifluoromethylthio or by the group NR4R5, the pharmaceutically utilizable salts thereof, a process for the preparation thereof and the use thereof as medicament for the treatment of hypertension, cardiac insufficiency and disturbances of peripheral circulation.
Patent IL-99984-A0 (IL)
Title: Chimeric fibroblast growth factors
IPC: C12N7/00
Filed: 1991-11-07
Abstract: The present invention relates to novel chimeric fibroblast growth factors (FGF) wherein the alanine at amino acid 3 and serine 5 of native human recombinant basic fibroblast growth factor are replaced with glutamic acid. The N-terminus sequence of the present chimeric FGFs identify homology with that of human acidic fibroblast growth factor. The mitogenic properties of the native human recombinant basic FGF are exhibited by the present chimeric FGFs, and they are efficiently expressed in E. coli at significantly greater yields that previously reported. Novel variants of this new glu<3,5> basic fibroblast growth factor, such as those in which cysteine 78 and cysteine 96 are replaced, e.g., with serine or other amino acids, to produce stabilized versions of the glu<3,5> basic FGF and eliminate disulfide scrambled forms, are also described. <IMAGE>
Patent AU-PN304895-A0 (AU)
Title: Device for detecting and recording snoring
IPC: A61B5/113
Filed: 1995-05-19
Abstract: PCT No. PCT/AU96/00306 Sec. 371 Date Feb. 19, 1998 Sec. 102(e) Date Feb. 19, 1998 PCT Filed May 20, 1996 PCT Pub. No. WO96/36279 PCT Pub. Date Nov. 21, 1996A device and method for detecting and recording the snoring of a patient. The device comprises a piezoelectric sensor, placed below a sleeping patient on a mattress, which generates signals representative of the sub-audible vibrations of the patient's airway which are present during a snore. The signals generated by the sensor can be amplified by an amplifier and processed by a signal processing circuit. The sensor can also generate signals representative of the patient's breathing cycle and general movement of the patient. The signal processing circuit can be adapted to discriminate the signals generated by the sensor and then output these signals for analysis. The output can be used to determine the presence of snoring by the patient and the snoring pattern can also be used to detect episodes of obstructive sleep apnea.
Patent AU-PP996499-A0 (AU)
Title: A treatment for hypertension caused by pre-eclampsia
IPC: A61M16/00
Filed: 1999-04-23
Abstract: An apparatus and a method for the treatment of an upper airway flow limitation, the apparatus including a means to detect an interruption in an upper airway inspiratory flow rate of the patient and further including a treatment means which treats the upper airway flow limitation on detection of the interruption cycle.
Patent FI-20040141-A0 (FI)
Inventor: SAHINOJA MIKKO
IPC: H04Q7/32
Filed: 2004-01-30
Abstract: The invention relates to a method for defining the nodes of a management structure used in device management in a device management system. In the arrangement, case sensitivity information is associated with at least one node to define whether to distinguish between upper-case and lower-case letters. At least one node is defined according to the case sensitivity information.
Patent FI-20041177-A0 (FI)
Inventor: KURITTU MINNA
IPC: B07C/
Filed: 2004-09-10
Abstract: The invention relates to the marking of a material (18) with identifier marks (16), the material thus marked, and verification of the genuineness of a product on the basis of the marks. In accordance with the invention, an optical brightener is incorporated in the material (18), and marking is performed by reducing the brightness of the material at a selected location by directing local heating to this location, the mark (16) thus produced appearing with a darker shade than its environment in ultraviolet light (20). The marking is based on partial or complete destruction of the brightening effect of the optical brightener under heating. The invention is suitable for providing e.g. coated paper and board containing an optical brightener with identifier marks for preventing falsifications.
Patent IL-103768-A0 (IL)
Title: Heat exchanger elements and method and apparatus for their manufacture
IPC: B21C37/22
Filed: 1992-11-17
Abstract: The invention relates to a method and a device for manufacturing heat-exchanger elements and to a corresponding heat-exchanger element consisting of a tubular main body (1) and ribs (2) which enlarge its heat-exchanging surface. In order to be able to attach ribs (2) by a continuous method and with a low outlay on equipment, even in the case of main-body profiles (1), the cross-section of which has a large width in relation to its height, the ribs (2) are formed by rib sheets which are drawn off from a roll of sheet metal, are provided with V-shaped or rounded corrugations in profiling devices (3), are positioned on the broad sides (1a) of the main-body profile (1) and are welded to the latter. The application of the profiled rib sheets (2), their positioning in relation to the main-body profile (1) and the movement of the main-body profile (1) in the longitudinal direction are accomplished by means of a special driving apparatus (6a,6b,6c). Welding is preferably performed by means of laser heads (7a). 
<IMAGE>
Patent IL-105418-A0 (IL)
Title: Melt-processable polymer blends and their production
IPC: C08L33/06
Filed: 1993-04-16
Abstract: Polymer containing a high percentage of vinyl alcohol units may be blended or formed into a segmented polymer with alkyl methacrylate unsaturated organic acid copolymer and processed into sheet, film, fiber and other objects which exhibit an useful balance of barrier and strength properties.
Patent IL-107213-A0 (IL)
Title: Modified ciliary neurotrophic factors
IPC: A61P25/28
Filed: 1993-10-08
Abstract: Modified ciliary neurotrophic factors and methods for their production and therapeutic use. Also described is a method of screening for novel therapeutic proteins by determining altered electrophoretic binding properties.
Patent IL-108027-A0 (IL)
Title: 3,5-Substituted aminobenzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them
IPC: A61K31/165
Filed: 1993-12-15
Abstract: Benzoylguanidines of the formula I <IMAGE>  having one of the substituents R(1), R(2), R(3) or R(4):  an amino group <IMAGE> where R(5) and R(6) are, inter alia, H or alkyl, or R(5) and R(6), together with the N atom, are a 5-7-membered ring, and the other substituents R(1), R(2), R(3) and R(4) are in each case: H, Hal, CN, CF3, NO2, CF3-O-, CmF2m+1-CH2-O- or R(11)-CqH2q -Xp-, X is O or NR(12) and R(11) is H, (cyclo)alkyl or phenyl, with R(1) and R(4) not being hydrogen simultaneously,  are described. The compounds I possess very good anti-arrhythmic and cardio-protective properties but do not have any undesirable salidiuretic properties. In addition, they exhibit protective properties against ischaemically-induced damage in vivo and in vitro in various organs, and also gastroprotective properties as a result of inhibiting gastric acid secretion. In addition to this, they are notable for their inhibitory effect on the proliferation of cells.
Patent IL-110666-A0 (IL)
Title: Gel cassette for enhanced electrophoretic separation and preparation thereof
IPC: G01N27/447
Filed: 1994-08-15
Abstract: A gel cassette useful in electrophoretic separation of molecular fragments is disclosed, in which a gelatinous substrate is uniquely configured to concentrate similar separated fragments. Containment means is also disclosed which provides for the desired configuration of the substrate. The containment means further includes a cover design which locks into an open position to eliminate cross contamination. In addition, processes for the preparation of such cassettes and for use of the cassettes in separation and transfer apparatus are disclosed.
Patent IL-143326-A0 (IL)
Title: Method of cloning porcine animals
IPC: C12N5/074
Filed: 1999-11-12
Abstract: The present invention relates to materials and methods for cloning porcine animals. The invention relates in part to totipotent cells useful for cloning porcine animals, porcine embryos produced from such cells by employing nuclear transfer techniques, and porcine animals that arise from such cells and embryos. <IMAGE>
Patent IL-147311-A0 (IL)
Title: Method and device for pyrolizing and gasifying organic substances or substance mixtures
IPC: C10B49/16
Filed: 2000-06-27
Abstract: An apparatus for pyrolysis and gasification of organic substances and mixtures thereof is provided with a pyrolysis reactor ( 1 ), a fluidized-bed firing ( 3 ) for pyrolysis residue, a reaction zone ( 2 ) for the pyrolysis gases ( 13 ) and circulating fluidized-bed material ( 35 ). The pyrolysis reactor ( 1 ) has a sluice for introducing application material ( 10 ) thereinto. An inlet for the fluidized-bed material ( 35 ) is disposed next to the combustion fluidized bed ( 3 ). Transport apparatus ( 14 ) for mixture of solid pyrolysis residue and circulating fluidized bed material ( 35 ) is disposed at or near a bottom of the fluidized bed ( 3 ) and lower end of the pyrolysis reactor ( 1 ). An overflow is situated at or near the top of the fluidized bed ( 3 ) while a heat transfer member is positioned within the reaction zone ( 2 ).
Patent IL-149994-A0 (IL)
Title: THE COMBINATION OF SEROTONIN REUPTAKE INHIBITOR AND A 5-HT2c ANTAGONIST, INVERSE AGONIST OR PARTIAL AGONIST
IPC: A61K31/445
Filed: 2000-12-06
Abstract: The present invention relates to the use of compounds and compositions of compounds having serotonin reuptake inhibiting activity and 5-HT 2C  antagonistic, partial agonistic or inverse agonistic activity for the for the treatment of depression and other affective disorders. The combined serotonin reuptake inhibiting effect and the 5-HT 2C  antagonistic, partial agonistic or inverse agonistic effect may reside within the same chemical compound or in two different chemical compounds.